Oxford Biomedica to host webinar showcasing the TetraVecta™ system
September 07, 2023 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica to host webinar showcasing the TetraVectaTM system Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led...
Oxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programs
September 14, 2022 07:00 ET
|
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programs Bedford, Massachusetts – September 14, 2022: Oxford Biomedica Solutions LLC, an Oxford...
Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology
March 11, 2022 07:00 ET
|
Oxford BioMedica plc
Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new customers Oxford, UK – 11 March 2022: Oxford Biomedica plc...